1 Product identity
Ingredient risk
Not yet assessed
D-Mannose
BrandBio-Tech Pharmacal→Fiber and Other Nutrients Powder 1 ingredients DSLD #319929Net contents: 1.76 Ounce(s)
Target: Adults and Children 4 years and above
DSLD entry: 2025-01-23
2 Ingredients (1)
IngredientGroupSafety
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
D-Mannose — Limited Evidence
⚠ GI bloating, diarrhea at high doses
⚠ May affect blood glucose monitoring
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID319929
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2025-01-23
6 More from Bio-Tech Pharmacal
View Bio-Tech Pharmacal Safety Scorecard → 15 products
Cal-CitrateCarnitineCu-1.5D3PlusD3PlusEVAC7 Cite this page
Vancouver
Pkhakadze G. D-Mannose — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 25]. Available from: https://supplement.ge/products/d-mannose-319929/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG